Ipca Laboratories has received voluntary action indicated (VAI) classification from the United States Food and Drug Administration (USFDA) for its Ratlam, Madhya Pradesh manufacturing facility. USFDA inspected the company’s said manufacturing facility from June 05, 2023 to June 13, 2023. This facility is considered to be in a minimally acceptable state of compliance with regard to current good manufacturing practice (CGMP).
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.
